{
    "Trade/Device Name(s)": [
        "Elecsys CK-MB STAT Immunoassay",
        "Elecsys CK-MB Immunoassay",
        "CK-MB STAT Immunoassay",
        "CK-MB Immunoassay"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K132571",
    "Predicate Device Reference 510(k) Number(s)": [
        "K022654"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JHY"
    ],
    "Summary Letter Date": "October 18, 2013",
    "Summary Letter Received Date": "August 15, 2013",
    "Submission Date": "August 14, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1215"
    ],
    "Regulation Name(s)": [
        "Creatine phosphokinase/creatine kinase or isoenzymes test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "CK-MB (MB isoenzyme of creatine kinase)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "K2-EDTA tube",
        "K3-EDTA tube",
        "Lithium heparin tube",
        "Sodium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Elecsys immunoassay analyzers",
        "cobas e 411 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescent immunoassay (ECLIA)",
        "Two-step sandwich immunoassay with streptavidin microparticles"
    ],
    "Methodologies": [
        "Immunoassay",
        "Quantitative colorimetric method"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Elecsys CK-MB STAT and Elecsys CK-MB immunoassays for quantitative measurement of CK-MB isoenzyme using ECLIA on Elecsys and cobas e analyzers.",
    "Indications for Use Summary": "Immunoassay for the in vitro quantitative determination of the MB isoenzyme of creatine kinase in human serum and plasma, used as an aid in the diagnosis of myocardial infarction on Elecsys and cobas e immunoassay analyzers.",
    "fda_folder": "Clinical Chemistry"
}